These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1280 related items for PubMed ID: 27145854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X, Wang Y, Peng B.
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA.
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [Abstract] [Full Text] [Related]

  • 7. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
    Pasqua L, Leggio A, Sisci D, Andò S, Morelli C.
    Mini Rev Med Chem; 2016 Jan; 16(9):743-53. PubMed ID: 26996622
    [Abstract] [Full Text] [Related]

  • 8. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W, Liu M, Liu A, Zhai G.
    Curr Pharm Des; 2017 Jan; 23(23):3367-3382. PubMed ID: 27784244
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery.
    Sábio RM, Meneguin AB, Ribeiro TC, Silva RR, Chorilli M.
    Int J Pharm; 2019 Jun 10; 564():379-409. PubMed ID: 31028801
    [Abstract] [Full Text] [Related]

  • 12. Preparation and Controllability of Mesoporous Silica Nanoparticles.
    Yamamoto E, Kuroda K.
    Enzymes; 2018 Jun 10; 44():1-10. PubMed ID: 30360809
    [Abstract] [Full Text] [Related]

  • 13. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y, Fu J, Wang T, Lu X.
    Acta Biomater; 2017 Mar 15; 51():471-478. PubMed ID: 28131940
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W, Ge P, Niu B, Zhang X, Liu J, Xie J.
    J Colloid Interface Sci; 2018 Oct 01; 527():141-150. PubMed ID: 29787950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS.
    Small; 2010 Sep 20; 6(18):1952-67. PubMed ID: 20690133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.